N60.1
Diffuse cystic mastopathy
Clinical Classification Guidelines
Inclusion Terms
- Cystic breast
- Fibrocystic disease of breast
Excludes Type 1
- diffuse cystic mastopathy with epithelial proliferation (N60.3-)
Medical Intelligence & Overview
Diffuse cystic mastopathy, also known as fibrocystic breast disease, is a common benign (non-cancerous) condition characterized by the presence of cysts, fibrosis, and nodular changes within the breast tissue. It often affects women of reproductive age and can cause noticeable changes in breast size, tenderness, or discomfort. Although it can be concerning due to the changes in the breast tissue, this condition is not cancerous and is typically manageable with appropriate care and observation.
Causes & Symptoms
Clinical Causes: Hormonal fluctuations, especially involving estrogen and progesterone, which influence breast tissue growth and cyst formation. Genetic predisposition, as it can run in families. Diet and lifestyle factors that may influence hormonal balance. Repeated cycles of hormone changes during menstrual cycles. Certain medications that affect hormonal levels.
Key Symptoms: Breast tenderness or pain, often worsening before menstruation. Noticeable lumps or nodules within the breast tissue. Swelling or a feeling of fullness in the breasts. Changes in breast size or shape during menstrual cycles. Discrete, fluid-filled cysts that may be tender or palpable. No symptoms in some cases, with changes detected during routine examination or imaging.
Diagnostic & Treatment
Diagnosis Path: Clinical breast exam to identify palpable lumps or areas of tenderness. Mammography, which can reveal cysts, calcifications, or fibrous tissue changes. Ultrasound imaging to differentiate between cystic (fluid-filled) and solid masses. Fine-needle aspiration or biopsy in certain cases to confirm the nature of cysts and exclude other conditions. Monitoring over time to assess the progression or resolution of symptoms.
Treatment Protocols: Lifestyle modifications, including wearing well-fitted bras and reducing caffeine intake, may help alleviate symptoms. Over-the-counter pain relievers such as acetaminophen or NSAIDs to manage discomfort. Application of warm or cold compresses to reduce swelling and ease pain. Hormonal therapy in some cases to regulate cycle-related symptoms, as recommended by a healthcare provider. Regular follow-up and imaging to monitor cysts and tissue changes. Surgical removal of cysts is rarely necessary unless they are large, persistent, or cause significant discomfort.
Clinical Advice & FAQs
Billing Guidance
Is N60.1 a billable ICD-10 code?
Yes, N60.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N60.1?
Clinical documentation must specify the nature of Diffuse cystic mastopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
